MARY BOUDREAU: Open Payments
NPI 1730523598 · MASON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,257 in 132 payments from 25 companies in 2025. Trend: 2023 $1,632 · 2024 $2,302 · 2025 $3,257
Food & beverage: $3,257
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 26 | $706 |
| Gilead Sciences, Inc. | 15 | $695 |
| PFIZER INC. | 10 | $264 |
| Novo Nordisk Inc | 12 | $230 |
| AstraZeneca Pharmaceuticals LP | 4 | $153 |
| GlaxoSmithKline, LLC. | 8 | $147 |
| Merck Sharp & Dohme LLC | 6 | $119 |
| Otsuka America Pharmaceutical, Inc. | 5 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $102 |
| ABBVIE INC. | 5 | $85 |
Products named: DOVATO, CABENUVA, AIRSUPRA, RUKOBIA, NURTEC ODT, Wegovy, REXULTI, Kerendia.
Industry payments across MI — which companies pay providers there.
